Dossier
Rising Pharma Holdings
Coverage of Rising Pharma Holdings in the Nexus archive.
- Recall alert: Cetirizine Hydrochloride recalled over cross-contamination
The FDA has issued a nationwide recall of four lots of Cetirizine Hydrochloride Tablets USP 5 mg produced by Unique Pharmaceuticals due to potential cross-contamination with ranitidine. The affected lots, identified by NDC 16571-401-10 and expiration dates 10/2028, may cause severe allergic reactions in individuals sensitive to ranitidine. No adverse effects have been reported, and consumers are advised to contact Rising Pharma Holdings for further information.
- Recall alert: 11K bottles of blood pressure medication recalled
The FDA recalled 11,460 bottles of 25mg chlorthalidone tablets due to failing dissolution specifications, distributed by Rising Pharma Holdings. The Class II recall indicates potential temporary adverse health effects.